Page last updated: 2024-09-05

sb 203580 and Depression

sb 203580 has been researched along with Depression in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fan, C; Li, Y; Song, Q; Wang, P; Yang, M; Yu, SY1
Chen, XR; Han, QQ; Huang, HJ; Li, B; Liu, Q; Pilot, A; Wang, J; Wang, YL; Wu, GC; Yang, L; Yu, J; Yu, R; Zhu, XC1
Chang, L; Guo, J; Guo, Z; Li, C; Li, M; Wang, C; Wang, Q; Yan, P; Zha, Q1
Blakely, RD; Daws, LC; Hewlett, WA; Lindler, KM; Owens, AW; Zhu, CB1
Chen, YS; Cheng, YH; Chio, CC; Gean, PW; Kuo, JR1

Other Studies

5 other study(ies) available for sb 203580 and Depression

ArticleYear
Hippocampal CA1 βCaMKII mediates neuroinflammatory responses via COX-2/PGE2 signaling pathways in depression.
    Journal of neuroinflammation, 2018, Dec-08, Volume: 15, Issue:1

    Topics: Adenoviridae; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cyclooxygenase 2; Cytokines; Depression; Dinoprostone; Disease Models, Animal; Food Preferences; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Hippocampus; Imidazoles; Lipopolysaccharides; Male; Pyridines; Rats; Rats, Sprague-Dawley; RNA Interference; Stress, Psychological; Swimming

2018
Ghrelin exhibited antidepressant and anxiolytic effect via the p38-MAPK signaling pathway in hippocampus.
    Progress in neuro-psychopharmacology & biological psychiatry, 2019, 07-13, Volume: 93

    Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Depression; Disease Models, Animal; Gene Knockdown Techniques; Ghrelin; Hippocampus; Imidazoles; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Pyridines

2019
SB203580 reverses memory deficits and depression-like behavior induced by microinjection of Aβ
    Metabolic brain disease, 2017, Volume: 32, Issue:1

    Topics: Amyloid beta-Peptides; Animals; Behavior, Animal; Depression; Disease Models, Animal; Enzyme Inhibitors; Hippocampus; Imidazoles; Male; Maze Learning; Memory Disorders; Mice; Microinjections; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Phosphorylation; Pyridines; Signal Transduction

2017
Interleukin-1 receptor activation by systemic lipopolysaccharide induces behavioral despair linked to MAPK regulation of CNS serotonin transporters.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2010, Volume: 35, Issue:13

    Topics: Animals; Behavior, Animal; Brain; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Imidazoles; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; p38 Mitogen-Activated Protein Kinases; Pyridines; Receptors, Interleukin-1; Serotonin Plasma Membrane Transport Proteins; Synaptosomes

2010
Involvement of extracellular signal regulated kinases in traumatic brain injury-induced depression in rodents.
    Journal of neurotrauma, 2013, Jul-15, Volume: 30, Issue:14

    Topics: Animals; Anxiety; Blotting, Western; Brain Injuries; Coloring Agents; Depression; Extracellular Signal-Regulated MAP Kinases; Feeding Behavior; Fenclonine; Fluoxetine; Food Preferences; Imidazoles; Interpersonal Relations; Male; MAP Kinase Signaling System; Motor Activity; Pyridines; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin Agents; Swimming; Tetrazolium Salts

2013